Min-Yuan Chou

Hsinchu County/City, Taiwan Taiwan

Senior Principal Scientist at Industrial Technology Research Institute

Medical / Health Care / Pharmaceuticals

Our protein engineering team has established several core competences in developing recombinant protein technologies for both therapeutic and diagnostic applications. A unique non-antibody scaffold platform, Collabody, which utilizes a short triplex-forming collagen-like peptide (around 30 mers) to make multivalent protein binders has been developed and one drug candidate is currently in the late stage of non-clinical development. Other core technologies related to biotherapeutics have been developed, including: (1) mouse hybridomas for mAb screening using high-throughput Clonepix selection; (2) phage-display antibody fragments for fully-human mAb selection; (3) structure-based design for...